Literature DB >> 20177016

[18F]Fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy.

Ugo De Giorgi, Dino Amadori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20177016     DOI： 10.1200/JCO.2009.26.6866

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer.

Authors:  Aung Naing; Razelle Kurzrock; Angelika Burger; Sachin Gupta; Xiudong Lei; Naifa Busaidy; David Hong; Helen X Chen; Lawrence A Doyle; Lance K Heilbrun; Eric Rohren; Chaan Ng; Chandtip Chandhasin; Patricia LoRusso
Journal:  Clin Cancer Res       Date:  2011-07-12       Impact factor: 12.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.